Literature DB >> 28930030

Mild Illness during Outbreak of Shiga Toxin-Producing Escherichia coli O157 Infections Associated with Agricultural Show, Australia.

Bhakti R Vasant, Russell J Stafford, Amy V Jennison, Sonya M Bennett, Robert J Bell, Christine J Doyle, Jeannette R Young, Susan A Vlack, Paul Titmus, Debra El Saadi, Kari A J Jarvinen, Patricia Coward, Janine Barrett, Megan Staples, Rikki M A Graham, Helen V Smith, Stephen B Lambert.   

Abstract

During a large outbreak of Shiga toxin-producing Escherichia coli illness associated with an agricultural show in Australia, we used whole-genome sequencing to detect an IS1203v insertion in the Shiga toxin 2c subunit A gene of Shiga toxin-producing E. coli. Our study showed that clinical illness was mild, and hemolytic uremic syndrome was not detected.

Entities:  

Keywords:  Australia; Brisbane; Escherichia coli; HUS; STEC; Shiga toxin; Shiga toxin−producing E. coli; agricultural show; bacteria; hemolytic uremic syndrome; illness; infections; outbreak; whole-genome sequencing

Mesh:

Substances:

Year:  2017        PMID: 28930030      PMCID: PMC5621556          DOI: 10.3201/eid2310.161836

Source DB:  PubMed          Journal:  Emerg Infect Dis        ISSN: 1080-6040            Impact factor:   6.883


Shiga toxin−producing Escherichia coli (STEC) is a major cause of serious human gastrointestinal illness and has the potential to cause life-threatening complications, such as hemolytic uremic syndrome (HUS) (). An average of 0.4 cases of STEC illness per 100,000 persons per year are reported to public health authorities in Australia (). Disease severity can range from asymptomatic infection to serious and sometimes fatal illness, particularly in young children and the elderly (,). Healthy ruminants, particularly cattle, are the reservoir for STEC (). Human infection with STEC usually occurs as a result of inadvertent ingestion of fecal matter after consumption of contaminated food, water, or unpasteurized milk; contact with animals or their environments; or secondarily, through contact with infected humans (,). In the largest previously reported outbreak of STEC illness in Australia in 1995, which was associated with consumption of mettwurst (uncooked, semidry, fermented sausages), HUS developed in 23 of the 51 case-patients identified, and there was 1 death ().

The Study

A multidisciplinary incident management team was established to investigate an outbreak of STEC illness associated with an annual agricultural show in Brisbane, Queensland, Australia, in August 2013 (Technical Appendix). The incident management team defined primary and secondary outbreak cases (Technical Appendix). Persons with laboratory-confirmed STEC infection associated with the outbreak and their household contacts were followed up until the point of microbiological evidence of clearance, which was defined as 2 consecutive negative stool samples collected >24 h apart (). Case-patients and contacts with a high risk for transmission (persons <5 years of age; persons unable to maintain good hygiene; or childcare, healthcare, aged care, or food preparation workers) were advised to avoid childcare and work settings in accordance with Queensland Health Guidelines (). Enhanced surveillance measures were implemented to assist with case finding (Technical Appendix). Medical practitioners were requested to avoid use of antimicrobial drugs for suspected case-patients with STEC infections because of previously reported associations between antimicrobial drug use and HUS (Technical Appendix). We developed a case−control study to obtain additional information related to animal contact, hand hygiene, and food consumption at the agricultural show (Technical Appendix). We analyzed data by using Epi Info 7 (Centers for Disease Control and Prevention, Atlanta, GA, USA) (Technical Appendix). STEC identified from human, environmental, and animal samples were serotyped for O and H antigens (Technical Appendix). Expression of Shiga toxin 1 (stx1) and stx2 genes was determined for selected isolates (Technical Appendix). Shiga toxin gene subtyping and whole-genome sequencing (WGS) analysis was performed (Technical Appendix). During August 21−September 27, 2013, we identified 57 outbreak-associated laboratory-confirmed case-patients with STEC infection: 54 confirmed primary case-patients, 1 probable primary case-patient, and 2 secondary case-patients (Figure 1). Of the 57 case-patients, 32 (56%) were female. Case-patients ranged in age from 1 to 77 (median 9) years; 31 (56%) case-patients were <10 years of age. Median incubation period after attending the agricultural show was 4 (range 1–11, 25th–75th percentile 3–5) days.
Figure 1

Illness onset dates for persons with cases of Shiga toxin−producing Escherichia coli illness associated with an agricultural show and non–outbreak-related cases, Brisbane, Queensland, Australia, 2013. Onset dates for 6 primary cases were not available. There was 1 asymptomatic secondary case.

Illness onset dates for persons with cases of Shiga toxin−producing Escherichia coli illness associated with an agricultural show and non–outbreak-related cases, Brisbane, Queensland, Australia, 2013. Onset dates for 6 primary cases were not available. There was 1 asymptomatic secondary case. Case-patients reported diarrhea (96%), abdominal pain (93%), bloody diarrhea (41%), and fever (32%) (Table 1). Seven case-patients were hospitalized. No cases of HUS or deaths were reported.
Table 1

Frequency of symptoms among persons, by age group, with cases of Shiga toxin−producing Escherichia coli illness associated with an agricultural show, Brisbane, Queensland, Australia, 2013

Symptom (self reported)
Age group, y. no. positive/no. responded (%)
All
1−4
5−14
>15
Diarrhea48/50 (96)16/17 (94)15/15 (100)17/18 (94)
Bloody diarrhea*19/46 (41)1/16 (6)7/13 (54)11/17 (65)
Abdominal pain37/40 (93)12/14 (86)9/9 (100)16/17 (94)
Fever14/44 (32)6/16 (38)4/14 (29)4/14 (29)

*Older children and adults were significantly more likely to report bloody diarrhea than children <5 years of age (p = 0.001 by χ2 test for linear trend).

*Older children and adults were significantly more likely to report bloody diarrhea than children <5 years of age (p = 0.001 by χ2 test for linear trend). Public Health Units followed up 40 case-patients until microbiological evidence of clearance; the remaining case-patients were lost to follow-up. Median duration of STEC excretion among primary case-patients was 18 (range 2−52) days (Table 2). After 27 days and 6 recurrent stools positive for STEC, and after acute diarrheal illness had resolved, 1 child was given azithromycin on day 40 for 3 days to hasten decolonization. Two consecutive stool specimens obtained >48 h after treatment with antimicrobial drugs was stopped were negative for STEC in this child. This patient did not have any adverse effects from azithromycin treatment.
Table 2

Clearance of STEC from stool samples of persons, by age group, during outbreak of Shiga toxin−producing Escherichia coli illness associated with an agricultural show, Brisbane, Queensland, Australia, 2013*

CharacteristicAll, n = 401−4 y, n = 125−14 y, n = 13>15 y, n = 15
Median clearance, d (range)18 (2–52)29 (5–37)23 (2–52)12 (2–28)
Mean clearance, d (SD)19 (12)24 (9)24 (12)12 (9)

*Time to clearance was based on onset of diarrhea. STEC, Shiga toxin−producing Escherichia coli.

*Time to clearance was based on onset of diarrhea. STEC, Shiga toxin−producing Escherichia coli. Forty-four of 55 primary case-patients and 28 household contacts who attended the agricultural show were included in the case−control study. Median age of case-patients was 8 (range 1−77) years, and median age of controls was 38 (range 1−70) years. We showed by using univariate analysis that case-patients were not more likely than controls to have entered the animal nursery at the show., Case-patients were more likely than controls to have had contact with lambs or goats, fed the animals, or had their hands licked by animals (Technical Appendix). We identified the same multilocus variable number tandem repeat and stx subtype genotype of E. coli O157:H- in human case-patients, animal bedding from the animal nursery before disposal, and fecal samples collected from lambs, goats, and calves (Technical Appendix). WGS and read mapping to an E. coli O157 reference genome showed that of the human, animal, and environmental isolates analyzed, all contained an IS1203v insertion that resulted in deletion of the first 494 bp of the stx2c subunit A gene (Figure 2). Expression of stx2 was not detected in these isolates by Immunocard STAT! EHEC (Meridian Bioscience, Cincinnati, OH, USA) and Shiga toxin Quik Chek (Alere, Waltham, MA, USA) lateral flow devices. No additional stx2 genes were identified, and no disruptions were detected in the stx1 gene regions of any of the isolates.
Figure 2

Alignment of genomic region from a representative isolate (EC_4844) showing insertion of IS1203v in the Shiga toxin 2 (stx2) gene region of Shiga toxin−producing Escherichia coli associated with an agricultural show, Brisbane, Queensland, Australia, 2013. CDS, coding DNA sequence.

Alignment of genomic region from a representative isolate (EC_4844) showing insertion of IS1203v in the Shiga toxin 2 (stx2) gene region of Shiga toxin−producing Escherichia coli associated with an agricultural show, Brisbane, Queensland, Australia, 2013. CDS, coding DNA sequence.

Conclusions

We found that STEC infection was associated with feeding lambs or goats, feeding animals, and having the hands licked by animals. The course of E. coli O157 infection was relatively mild; no cases of HUS were associated with this outbreak. Heiman et al. found that of 4,928 cases of 390 E. coli O157 illness outbreaks in the United States during 2003–2012, HUS was detected in 299 cases (6% of illnesses) (). HUS cases with stx1+/stx2−E. coli O157 isolates have been reported (,). We speculate that the absence of severe complications in this outbreak might have been caused, in part, by disruption of the stx2 subunit A gene by the IS1203v insertion, which resulted in lack of expression or a nonfunctional Stx2 toxin. The proportion of case-patients reporting bloody diarrhea (19/46, 41%) was also lower than previously reported. Ethelberg et al. reported that 69% (56/81) of case-patients in Denmark infected with E. coli O157 had bloody diarrhea (). A recent retrospective cohort study from England reported that 61% (2,027/3,323) of symptomatic case-patients infected with E. coli O157 had bloody diarrhea. Bloody diarrhea was reported to be a risk factor for HUS (odds ratio 2.10; p = 0.001) (). In the outbreak we studied, children <5 years of age were less likely than older children and adults to report bloody diarrhea. STEC infection should be actively considered for young children with nonbloody diarrhea who were exposed to potential sources of STEC. In this outbreak, 1 child was given azithromycin for 3 days to hasten decolonization some weeks after the acute diarrheal illness had resolved. Antimicrobial drugs are generally not recommended to hasten STEC decolonization because of major associations with HUS (). Recommendations to avoid high-risk activities (such as childcare attendance) might place a major socioeconomic burden on STEC carriers and their families. Further studies are required to assess whether WGS can provide useful information for safe administration of antimicrobial drugs for treatment of acute illness caused by STEC, or when chronic shedding becomes established. Our comprehensive study of a large outbreak E. coli O157 illness, characterized by an IS1203v insertion disrupting the stx2c subunit A gene, showed mild clinical illness and an absence of HUS. Further characterization by virulence studies on isolates with this stx2c subunit A gene disruption might provide further insights into the mild illness caused by this strain.

Technical Appendix

Additional information on mild illness during outbreak of Shiga toxin−producing Escherichia coli O157 infections associated with agricultural show, Australia.
  11 in total

1.  ABO and P1 blood group antigen expression and stx genotype and outcome of childhood Escherichia coli O157:H7 infections.

Authors:  Srdjan Jelacic; Cheryl L Wobbe; Daniel R Boster; Marcia A Ciol; Sandra L Watkins; Phillip I Tarr; Ann E Stapleton
Journal:  J Infect Dis       Date:  2002-01-03       Impact factor: 5.226

Review 2.  Review of Shiga-toxin-producing Escherichia coli (STEC) and their significance in dairy production.

Authors:  Choreh Farrokh; Kieran Jordan; Frederic Auvray; Kathleen Glass; Hanne Oppegaard; Sabrina Raynaud; Delphine Thevenot; Robin Condron; Koen De Reu; Alexander Govaris; Klaus Heggum; Marc Heyndrickx; Joerg Hummerjohann; Denise Lindsay; Stephane Miszczycha; Sylvie Moussiegt; Karen Verstraete; Olivier Cerf
Journal:  Int J Food Microbiol       Date:  2012-08-14       Impact factor: 5.277

Review 3.  Shiga-toxin-producing Escherichia coli and haemolytic uraemic syndrome.

Authors:  Phillip I Tarr; Carrie A Gordon; Wayne L Chandler
Journal:  Lancet       Date:  2005 Mar 19-25       Impact factor: 79.321

4.  Community outbreak of hemolytic uremic syndrome attributable to Escherichia coli O111:NM--South Australia 1995.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  1995-07-28       Impact factor: 17.586

5.  Sporadic cases of haemolytic-uraemic syndrome associated with faecal cytotoxin and cytotoxin-producing Escherichia coli in stools.

Authors:  M A Karmali; B T Steele; M Petric; C Lim
Journal:  Lancet       Date:  1983-03-19       Impact factor: 79.321

6.  Isolation of an Escherichia coli O157:H7 strain producing Shiga toxin 1 but not Shiga toxin 2 from a patient with hemolytic uremic syndrome in Korea.

Authors:  Y B Kim; J Okuda; C Matsumoto; T Morigaki; N Asai; H Watanabe; M Nishibuchi
Journal:  FEMS Microbiol Lett       Date:  1998-09-01       Impact factor: 2.742

Review 7.  Pathogenesis and diagnosis of Shiga toxin-producing Escherichia coli infections.

Authors:  J C Paton; A W Paton
Journal:  Clin Microbiol Rev       Date:  1998-07       Impact factor: 26.132

Review 8.  Escherichia coli O157 Outbreaks in the United States, 2003-2012.

Authors:  Katherine E Heiman; Rajal K Mody; Shacara D Johnson; Patricia M Griffin; L Hannah Gould
Journal:  Emerg Infect Dis       Date:  2015-08       Impact factor: 6.883

9.  Virulence factors for hemolytic uremic syndrome, Denmark.

Authors:  Steen Ethelberg; Katharina E P Olsen; Flemming Scheutz; Charlotte Jensen; Peter Schiellerup; Jørgen Enberg; Andreas Munk Petersen; Bente Olesen; Peter Gerner-Smidt; Kåre Mølbak
Journal:  Emerg Infect Dis       Date:  2004-05       Impact factor: 6.883

10.  Disease severity of Shiga toxin-producing E. coli O157 and factors influencing the development of typical haemolytic uraemic syndrome: a retrospective cohort study, 2009-2012.

Authors:  N Launders; L Byrne; C Jenkins; K Harker; A Charlett; G K Adak
Journal:  BMJ Open       Date:  2016-01-29       Impact factor: 2.692

View more
  4 in total

1.  Molecular Prediction of the O157:H-Negative Phenotype Prevalent in Australian Shiga Toxin-Producing Escherichia coli Cases Improves Concordance of In Silico Serotyping with Phenotypic Motility.

Authors:  Alexander P Pintara; Christine J D Guglielmino; Irani U Rathnayake; Flavia Huygens; Amy V Jennison
Journal:  J Clin Microbiol       Date:  2018-03-26       Impact factor: 5.948

2.  Characterization of Atypical Shiga Toxin Gene Sequences and Description of Stx2j, a New Subtype.

Authors:  Alexander Gill; Forest Dussault; Tanis McMahon; Nicholas Petronella; Xiong Wang; Elizabeth Cebelinski; Flemming Scheutz; Kelly Weedmark; Burton Blais; Catherine Carrillo
Journal:  J Clin Microbiol       Date:  2022-03-16       Impact factor: 11.677

3.  Emergence and divergence of major lineages of Shiga-toxin-producing Escherichia coli in Australia.

Authors:  Danielle J Ingle; Anders Gonçalves da Silva; Mary Valcanis; Susan A Ballard; Torsten Seemann; Amy V Jennison; Ivan Bastian; Rolf Wise; Martyn D Kirk; Benjamin P Howden; Deborah A Williamson
Journal:  Microb Genom       Date:  2019-05-20

4.  Shiga Toxin-Producing Escherichia coli Infection in Jönköping County, Sweden: Occurrence and Molecular Characteristics in Correlation With Clinical Symptoms and Duration of stx Shedding.

Authors:  Xiangning Bai; Sara Mernelius; Cecilia Jernberg; Ing-Marie Einemo; Stefan Monecke; Ralf Ehricht; Sture Löfgren; Andreas Matussek
Journal:  Front Cell Infect Microbiol       Date:  2018-05-01       Impact factor: 5.293

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.